Aptevo Therapeutics (APVO) Misses Q3 EPS by 15c

Aptevo Therapeutics (NASDAQ: APVO) reported Q3 EPS of ($1.50), $0.15 worse than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue
• Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue